Literature DB >> 20881421

Relationship between reactive oxygen metabolites and carotid intima-media thickness in subjects with hypercholesterolemia.

Kazuhiko Kotani1, Harumi Koibuchi, Michiaki Miyamoto, Toshiyuki Yamada, Nobuyuki Taniguchi.   

Abstract

OBJECTIVE: It was the aim of this study to investigate whether there is any relationship between oxidative stress, as assessed by the diacron reactive oxygen metabolite (d-ROM) test, and carotid atherosclerosis among hypercholesterolemic patients. SUBJECTS AND METHODS: A well-defined group of patients with type II hypercholesterolemia (n = 81, mean age 59 years) was studied to observe the correlation between the levels of serum d-ROMs and carotid artery intima-media thickness (IMT) using B-mode ultrasound, in relation to the traditional atherosclerotic risk factors (age, sex, smoking, body mass index, blood pressure, glucose and lipid panels).
RESULTS: The mean level in low-density lipoprotein cholesterol (LDL-C) in this population was 4.45 mmol/l, d-ROMs were 323.2 Carr U, and IMT was 0.91 mm. A multiple regression analysis revealed a positive and significant correlation between IMT and d-ROMs (β = 0.27, p < 0.05), along with age and LDL-C.
CONCLUSION: These results indicate that the increased oxidative stress levels using the d-ROM test, independent of aging and increased LDL-C levels, may be associated with carotid atherosclerosis even in hypercholesterolemic patients.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881421     DOI: 10.1159/000320312

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  13 in total

1.  Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission.

Authors:  Arata Nakajima; Yasuchika Aoki; Masato Sonobe; Hiroshi Takahashi; Masahiko Saito; Koichi Nakagawa
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

2.  Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome.

Authors:  Masaki Tanito; Sachiko Kaidzu; Yasuyuki Takai; Akihiro Ohira
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

3.  Correlation between Systemic Oxidative Stress and Intraocular Pressure Level.

Authors:  Masaki Tanito; Sachiko Kaidzu; Yasuyuki Takai; Akihiro Ohira
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

4.  Factors affecting high-sensitivity cardiac troponin T elevation in Japanese metabolic syndrome patients.

Authors:  Takashi Hitsumoto; Kohji Shirai
Journal:  Diabetes Metab Syndr Obes       Date:  2015-03-10       Impact factor: 3.168

5.  Association between systemic oxidative stress and visual field damage in open-angle glaucoma.

Authors:  Masaki Tanito; Sachiko Kaidzu; Yasuyuki Takai; Akihiro Ohira
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

6.  Atherosclerosis-related biomarkers in women with endometriosis: The effects of dienogest and oral contraceptive therapy.

Authors:  Eiko Maeda; Akemi Koshiba; Taisuke Mori; Fumitake Ito; Hisashi Kataoka; Hiroyuki Okimura; Takuya Sugahara; Yosuke Tarumi; Izumi Kusuki; Khaleque N Khan; Jo Kitawaki
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2020-04-23

7.  Association between Serum Uric Acid and Oxidative Stress in Korean Adults.

Authors:  Eun Jeong Ok; Kiyoung Kim; Sat Byul Park
Journal:  Korean J Fam Med       Date:  2018-09-10

8.  Status of systemic oxidative stress during therapeutic hypothermia in patients with post-cardiac arrest syndrome.

Authors:  Kenji Dohi; Kazuyuki Miyamoto; Kenichiro Fukuda; Shunsuke Nakamura; Munetaka Hayashi; Hirokazu Ohtaki; Seiji Shioda; Tohru Aruga
Journal:  Oxid Med Cell Longev       Date:  2013-08-26       Impact factor: 6.543

9.  Longitudinal relationship between plasma reactive oxygen metabolites and periodontal condition in the maintenance phase of periodontal treatment.

Authors:  Tatsuya Machida; Takaaki Tomofuji; Daisuke Ekuni; Mayu Yamane; Toshiki Yoneda; Yuya Kawabata; Kota Kataoka; Naofumi Tamaki; Manabu Morita
Journal:  Dis Markers       Date:  2014-04-16       Impact factor: 3.434

10.  Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis.

Authors:  Arata Nakajima; Keiichiro Terayama; Masato Sonobe; Yasuchika Aoki; Hiroshi Takahashi; Yorikazu Akatsu; Junya Saito; Shinji Taniguchi; Manabu Yamada; Ayako Kubota; Koichi Nakagawa
Journal:  BMC Rheumatol       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.